n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid has been researched along with Liver Neoplasms in 80 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 30 (37.50) | 18.2507 |
2000's | 48 (60.00) | 29.6817 |
2010's | 2 (2.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, JS; Chung, JB; Kim, BR; Kim, JH; Kim, KS; Kim, KW; Kim, MJ; Lee, JT; Park, YN | 1 |
Grossman, AB; Monson, JP; Nowosinska, E; Planche, K; Power, N; Reznek, RH; Rockall, AG | 1 |
Bosmans, H; Chen, F; DeKeyzer, F; Feng, Y; Li, J; Marchal, G; Ni, Y; Wang, H; Yu, J | 1 |
Ba-Ssalamah, A; Gruenberger, T; Kaczirek, K; Kulemann, V; Schima, W; Tamandl, D; Weber, M; Wrba, F | 1 |
Alexander Grant, L; Burke, C; Goh, V; Griffin, N | 1 |
Choi, D; Kim, H; Kim, SH; Kim, SK; Lee, SJ; Lee, WJ; Lim, HK; Lim, JH; Seo, JW | 1 |
Hahn, PF; Kalra, MK; Michael, M; Sahani, DV; Saini, S | 1 |
Adriaens, P; Bogaert, J; Bosmans, H; Cresens, E; Dymarkowski, S; Marchal, G; Ni, Y; Verbruggen, A; Zhang, H | 1 |
Körner, M; Linsenmaier, U; Pfeifer, KJ; Rieger, J; Rock, C; Wirth, S | 1 |
Burkill, GJ; Healy, JC; King, LJ; Scurr, E | 1 |
Burkill, GJ; Healy, JC; King, LJ; Murray-Lyons, I; Scurr, ED; Vlavianos, P | 1 |
Schima, W | 1 |
Chen, KM; Wang, DB; Wang, YX; Zeng, MS; Zhou, KR | 1 |
de Beeck, BO; Fagertun, H; Fog, AF; Kane, P; Martí-Bonmatí, L | 1 |
Dionne, G; Dufour, M; Godbout, MJ; Moisan, C; Morin, J; Serre, D; Traoré, AS; Younan, R | 1 |
Chang, RM; Guo, T; Zhang, XL; Zhang, YZ | 1 |
Batteux, F; Bedda, S; Calmus, Y; Chéreau, C; Conti, F; Goulvestre, C; Jaffray, P; Laurent, A; Soubrane, O; Tran, A; Tran-Van Nhieu, J; Weill, B | 1 |
Bartolozzi, C; Chiesa, A; Cioni, D; Cittadini, G; Donati, F; Gandini, G; Giovagnoni, A; Grazioli, L; Lencioni, R; Maass, J; Morana, G; Procacci, C | 1 |
Reimer, P; Schima, W; Schneider, G | 1 |
Ha, HK; Kim, AY; Kim, HJ; Kim, JC; Kim, KW; Kim, PN; Kim, TK; Lee, MG; Lee, YK; Park, MS; Park, SH | 1 |
Beziat, C; Lombard-Bohas, C; Mercier, C; Pilleul, F; Valette, PJ; Yzebe, D | 1 |
Kim, CS; Lee, JM; Youk, JH | 1 |
Choi, JS; Chung, JJ; Kim, JH; Kim, KW; Kim, MJ; Lee, WJ; Lim, JS; Oh, YT | 1 |
Ba-Ssalamah, A; Dirisamer, A; Happel, B; Kettenbach, J; Längle, F; Schima, W; Wrba, F | 1 |
Blake, M; Fischman, AJ; Hahn, PF; Kadavigere, R; Kalva, SP; Sahani, DV; Saini, S | 1 |
Fischman, AJ; Hahn, PF; Kalva, SP; Mueller, P; Ryan, D; Sahani, DV; Saini, S | 1 |
Kuribayashi, S; Tanimoto, A | 1 |
Goshima, S; Hirose, Y; Kanematsu, M; Kato, H; Kim, MJ; Kondo, H; Moriyama, N; Tsuge, U | 1 |
Aglietta, M; Anselmetti, GC; Campanella, D; Capussotti, L; Cirillo, S; Floriani, I; Galatola, G; Gallo, TM; Muratore, A; Regge, D | 1 |
Byun, JH; Kim, HJ; Kim, KW; Kim, PN; Lee, MG; Lee, MS; Shin, YM; Won, HJ | 1 |
Chung, JJ; Kim, KW; Kim, MJ | 1 |
Eser, C; Eser, G; Karabacakoglu, A; Karakose, S; Kayacetin, E | 1 |
Choi, JY; Chung, JJ; Kim, JH; Kim, KW; Kim, MJ; Kim, SH; Ko, HK; Lee, JT; Lim, JS; Oh, YT; Yoo, HS | 1 |
Adigüzel, Y; Haykir, R; Karabacakoğlu, A; Karaköse, S; Kayaçetin, E | 1 |
Brown, G; Husband, JE; Koh, DM; Meer, Z; Norman, AR | 1 |
Allen, SD; Brown, G; Chau, I; Collins, DJ; Cunningham, D; deSouza, NM; Husband, JE; Koh, DM; Leach, MO; Riddell, AM; Scurr, E | 1 |
Brown, G; Cook, GJ; Cunningham, D; Jackson, C; Koh, DM; Kong, G; Lewington, V; Sharma, B | 1 |
Borrello, JA; Brown, JJ; Lee, JK; Liou, J | 1 |
Baert, AL; Lodemann, KP; Marchal, G; Ni, Y; Rummeny, E; Yu, J; Zhang, X | 1 |
Bernardino, ME; Lee, JK; Noz, ME; Rofsky, NM; Weinreb, JC; Young, SW | 1 |
Mitchell, DG | 1 |
Baron, RL; Confer, SR; Davis, PL; Federle, MP; Murakami, T; Oliver, JH; Peterson, MS | 2 |
Earls, JP; Rofsky, NM | 1 |
Eisenberg, PJ; Hahn, PF; Mayo-smith, WW; Saini, S; Sharma, P; Slater, GJ | 1 |
Chezmar, JL; Redvanly, RD; Sewell, CW | 1 |
Bruneton, JN; Chevallier, P; Drouillard, J; Gordon, P; Lambrechts, M; Lecesne, R; Padovani, B; Raffaelli, C | 1 |
Eisenberg, LB; Kettritz, U; Schlund, JF; Semelka, RC; Wilbur, K | 1 |
Bjerknes, HS; Gordon, PB; Lundby, B; McGill, S; Sterud, AT; Torres, CG | 1 |
Ayton, V; Benjamin, I; Heaton, ND; Kane, PA; Karani, JB; Walters, HL; Williams, R | 1 |
Kurdziel, JC; Lundby, B; Nilsen, G; Op de Beeck, B; Rummeny, EJ; Torres, CG | 1 |
Ahlström, H; Ekholm, S; Fagertun, H; Hellström, M; Hemmingsson, A; Holtås, S; Isberg, B; Jonnson, E; Lönnemark-Magnusson, M; McGill, S; Wallengren, NO; Wang, C; Westman, L | 1 |
Anglade, MC; Coffin, C; Lonjedo, E; Marti-Bonmati, L; Mathieu, D; Poyatos, C | 1 |
Wang, C | 1 |
Fischbach, R; Heindel, W; Jung, G; Klaus, H; Krahe, T; Kugel, H; Lackner, K; Walter, C | 1 |
Alexandre, M; Caseiro-Alves, F; Coffin, CM; Diche, T; Mahfouz, A; Mathieu, D; Rahmouni, A; Vasile, N | 1 |
Caseiro-Alves, F; Coffin, C; Diche, T; Kobeiter, H; Mahfouz, A; Mathieu, D; Rahmouni, A | 1 |
Anderson, MW; Borello, JA; Bova, JG; Brown, JJ; Chezmar, JL; Dachman, AH; Federle, MP; Fenstermacher, M; Foster, GS; Francis, IR; Freeny, PC; Halford, HH; Harmon, B; Harms, SE; Johnson, CD; Kenney, PJ; Klippenstein, DL; Lee, JK; Mattrey, R; Mitchell, DG; Pelsang, RE; Rubin, DL; Saini, S; Semelka, RC; Turner, DA; Weinreb, JC | 1 |
Anderson, MW; Ballerini, R; Bennett, WF; Borrello, JA; Brown, JJ; Chezmar, J; Dachman, AH; Federle, M; Freeny, P; Gay, SB; Halford, HH; Harms, SE; Lee, JK; Mattrey, R; Mitchell, DG; Rifkin, M; Robison, RO; Rubin, DL; Saini, S; Schmiedl, UP; Semelka, RC; Sherwin, PF; Weinreb, J; Young, SW | 1 |
Bartolozzi, C; Cioni, D; Crocetti, L; Donati, F; Lencioni, R | 1 |
Balci, NC; Chung, JJ; Martin, DR; Semelka, RC; Wilber, K | 1 |
Burkill, GJ; Healy, JC; Mannion, EM | 1 |
de Jode, M; Gedroyc, WM; Joarder, R; Lamb, GA | 1 |
Biederer, J; Blume, J; Grimm, J; Heller, M; Müller-Hülsbeck, S | 1 |
Lai, LL; Mann, GN; Marx, HF; Wagman, LD | 1 |
Flemming, P; Galanski, M; Högemann, D; Kreipe, H | 1 |
De Cobelli, F; De Gaspari, A; Del Maschio, A | 1 |
Helmberger, T; Semelka, RC | 1 |
Döhring, W; Helmberger, TK; Jung, G; Laubenberger, J; Meurer, K; Reiser, MF; Rummeny, E; Sievers, K | 1 |
Ballerini, R; Bhat, S; Brown, J; Chezmar, J; Francis, IR; Getty, DJ; Harmon, B; Mattrey, RF; Pickett, RM; Saini, S; Schnall, MO; Seltzer, SE; Sica, G; Siegelman, ES; Swets, JA | 1 |
Eibl-Eibesfeldt, B; Hammerstingl, R; Lissner, J; Peqios, W; Schnell, B; Vogl, TJ | 1 |
Branding, G; Hamm, B; Lissner, J; Schnell, B; Taupitz, M; Vogl, TJ; Wolf, KJ | 1 |
Aicher, KP; Claussen, CD; Grönewäller, EF; Kopp, AF; Laniado, M | 1 |
Hartlapp, J; Kraheck, H; Layer, G; Reiser, M; Steudel, A | 1 |
Berthezène, Y; Brasch, RC; Clément, O; Mühler, A; Rosenau, W; Vexler, V | 1 |
Peters, PE; Rummeny, EJ | 1 |
Saini, S | 1 |
Eibl-Eibesfeldt, B; Hamm, B; Lissner, J; Schnell, B; Steiner, S; Vogl, TJ | 1 |
Ehrenheim, C; Gehl, HB; Hamm, B; Laniado, M; Lodemann, KP; Rummeny, E; Schmiedel, E; Steudel, A; Vogl, TG | 1 |
Bernardino, ME | 1 |
10 review(s) available for n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid and Liver Neoplasms
Article | Year |
---|---|
The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.
Topics: Bile Duct Neoplasms; Bile Ducts; Contrast Media; Edetic Acid; Gadolinium DTPA; Hepatocytes; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pyridoxal Phosphate | 2013 |
Safety and efficacy of Mangafodipir trisodium in patients with liver lesions and cirrhosis.
Topics: Contrast Media; Edetic Acid; Female; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate; Retrospective Studies; Safety | 2003 |
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.
Topics: Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Manganese; Meglumine; Organometallic Compounds; Pyridoxal Phosphate; Time Factors; Tomography, X-Ray Computed | 2004 |
[MRT of the liver. Clinical significance of nonspecific and liver-specific MRT contrast agents].
Topics: Chelating Agents; Contrast Media; Edetic Acid; Gadolinium; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Practice Patterns, Physicians'; Pyridoxal Phosphate | 2004 |
Imaging liver metastases: review and update.
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Gadolinium; Hepatic Artery; Humans; Image Enhancement; Iron; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Oxides; Portography; Pyridoxal Phosphate; Tomography, X-Ray Computed | 2006 |
Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging.
Topics: Adrenal Gland Diseases; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Contrast Media; Edetic Acid; Female; Humans; Kidney Diseases; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Pancreatic Diseases; Pyridoxal Phosphate | 1996 |
Unexpected MR-T1 enhancement of endocrine liver metastases with mangafodipir.
Topics: Adenoma, Islet Cell; Contrast Media; Edetic Acid; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pancreatic Neoplasms; Preoperative Care; Pyridoxal Phosphate | 1999 |
[Magnetic resonance imaging of the liver: what kind of contrast agents?].
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Focal Nodular Hyperplasia; Gadolinium DTPA; Humans; Iron; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Meglumine; Organometallic Compounds; Oxides; Pyridoxal Phosphate | 2001 |
New contrast agents for imaging the liver.
Topics: Animals; Contrast Media; Edetic Acid; Ferric Compounds; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pyridoxal Phosphate | 2001 |
[Status and development of new clinical contrast media for MR diagnosis of liver diseases].
Topics: Acetates; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate | 1992 |
30 trial(s) available for n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid and Liver Neoplasms
Article | Year |
---|---|
Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced versus mangafodipir trisodium-enhanced MR imaging.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Dextrans; Edetic Acid; False Negative Reactions; False Positive Reactions; Female; Ferrosoferric Oxide; Humans; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Oxides; Preoperative Care; Pyridoxal Phosphate; Sensitivity and Specificity | 2002 |
[Focal secondary malignant liver lesions: MnDPDP-enhanced MRT at 0.2 tesla vs. helical CT-arterioportography].
Topics: Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Portography; Prospective Studies; Pyridoxal Phosphate; Sensitivity and Specificity; Tomography, Spiral Computed | 2002 |
Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT.
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Edetic Acid; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Probability; Prospective Studies; Pyridoxal Phosphate; Radiographic Image Enhancement; Reference Values; Risk Assessment; Sensitivity and Specificity; Statistics, Nonparametric; Tomography, Spiral Computed | 2004 |
[Detection of liver metastases in colorectal cancer on chemotherapy. Comparative study between MRI with teslascan and computed tomography with intravenous contrast media].
Topics: Aged; Colorectal Neoplasms; Contrast Media; Edetic Acid; Feasibility Studies; Humans; Injections; Iodine; Liver Neoplasms; Magnetic Resonance Imaging; Prospective Studies; Pyridoxal Phosphate; Tomography, X-Ray Computed | 2004 |
Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients.
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Dextrans; Edetic Acid; Female; Ferrosoferric Oxide; Humans; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Oxides; Pyridoxal Phosphate | 2006 |
Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Hemangioma; Humans; Image Enhancement; Liver Abscess; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Pyridoxal Phosphate; Time Factors | 2006 |
Detection of hepatic metastasis: manganese- and ferucarbotran-enhanced MR imaging.
Topics: Adult; Aged; Contrast Media; Dextrans; Edetic Acid; Female; Ferrosoferric Oxide; Humans; Image Enhancement; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Oxides; Pyridoxal Phosphate; Reproducibility of Results; Sensitivity and Specificity | 2006 |
Diagnostic accuracy of rim and segmental MRI enhancement of colorectal hepatic metastasis after administration of mangafodipir trisodium.
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Edetic Acid; Female; Humans; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate; Reproducibility of Results; Sensitivity and Specificity | 2007 |
Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Predictive Value of Tests; Pyridoxal Phosphate; Sensitivity and Specificity | 1993 |
Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP).
Topics: Case-Control Studies; Contrast Media; Edetic Acid; Female; Humans; Image Processing, Computer-Assisted; Liver; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate | 1996 |
Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP).
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Confidence Intervals; Contrast Media; Edetic Acid; Female; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate | 1996 |
Mn-DPDP enhanced MR imaging of the liver: analysis of pulse sequence performance.
Topics: Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Image Enhancement; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate; Sensitivity and Specificity | 1996 |
Uptake of mangafodipir trisodium (MnDPDP) by hepatocellular carcinoma: correlation with unenhanced imaging findings and histopathologic features.
Topics: Adult; Biopsy; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Necrosis; Pyridoxal Phosphate | 1996 |
Tolerability and utility of mangafodipir trisodium injection (MnDPDP) at the dose of 5 mumol/kg body weight in detecting focal liver tumors: results of a phase III trial using an infusion technique.
Topics: Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Female; Humans; Infusions, Intravenous; Liver Neoplasms; Male; Manganese; Middle Aged; Pyridoxal Phosphate; Tomography, X-Ray Computed | 1996 |
MnDPDP for MR imaging of the liver. Results from the European phase III studies.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Europe; Female; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate; Safety | 1997 |
MnDPDP-enhanced MR imaging of the liver. Correlation with surgical findings.
Topics: Adolescent; Adult; Aged; Animals; Contrast Media; Edetic Acid; Female; Guinea Pigs; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate | 1997 |
MnDPDP for MR imaging of the liver. Results of an independent image evaluation of the European phase III studies.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Europe; Female; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate | 1997 |
Diagnostic efficacy of MnDPDP in MR imaging of the liver. A phase III multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Female; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate; Sweden | 1997 |
Tumoural portal vein thrombosis. Enhancement with MnDPDP.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Neoplastic Cells, Circulating; Portal Vein; Pyridoxal Phosphate; Thrombosis | 1997 |
Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging.
Topics: Adenoma, Liver Cell; Adult; Aged; Biopsy, Needle; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Follow-Up Studies; Humans; Hyperplasia; Image Enhancement; Injections, Intravenous; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate; Retrospective Studies | 1999 |
Safety and efficacy of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. multicenter phase III clinical trials (safety).
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Humans; Image Enhancement; Injections, Intravenous; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pain; Pregnancy; Pyridoxal Phosphate; Risk Assessment; Sensitivity and Specificity; Vomiting | 2000 |
Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Humans; Image Enhancement; Injections, Intravenous; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate; Sensitivity and Specificity | 2000 |
MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis.
Topics: Carcinoma, Hepatocellular; Edetic Acid; Female; Follow-Up Studies; Humans; Iodized Oil; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Prospective Studies; Pyridoxal Phosphate; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2000 |
[Comparison of biphasic spiral CT and MnDPDP-enhanced MRI in the detection and characterization of liver lesions].
Topics: Adenoma; Adult; Aged; Biopsy; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cysts; Diagnosis, Differential; Edetic Acid; Female; Focal Nodular Hyperplasia; Humans; Liver; Liver Diseases; Liver Neoplasms; Liver Regeneration; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate; Tomography, X-Ray Computed | 2001 |
MRI characteristics in focal hepatic disease before and after administration of MnDPDP: discriminant analysis as a diagnostic tool.
Topics: Adolescent; Adult; Aged; Breast Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Contrast Media; Discriminant Analysis; Edetic Acid; Female; Hemangioma; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate; Sensitivity and Specificity | 2002 |
Multimodality diagnosis of liver tumors: feature analysis with CT, liver-specific and contrast-enhanced MR, and a computer model.
Topics: Adult; Carcinoma, Hepatocellular; Computer Simulation; Contrast Media; Edetic Acid; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Manganese; Multivariate Analysis; Observer Variation; Pyridoxal Phosphate; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2002 |
[Magnetic resonance tomography of the hepatobiliary system: indications, limitations and outlook].
Topics: Biliary Tract Diseases; Biliary Tract Neoplasms; Cholangiography; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate | 1992 |
Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Evaluation Studies as Topic; Female; Humans; Image Processing, Computer-Assisted; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate | 1992 |
[Manganese DPDP as a contrast medium for MR tomography of focal liver lesions. Tolerance and image quality in 20 patients].
Topics: Adult; Contrast Media; Drug Tolerance; Edetic Acid; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate | 1992 |
[Manganese-DPDP in the MR tomography of malignant liver tumors. The initial results with a new hepatobiliary contrast agent].
Topics: Adult; Aged; Contrast Media; Drug Evaluation; Edetic Acid; Humans; Infusions, Intravenous; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Manganese; Middle Aged; Pyridoxal Phosphate; Sensitivity and Specificity | 1992 |
40 other study(ies) available for n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid and Liver Neoplasms
Article | Year |
---|---|
Mangafodipir trisodium-enhanced MRI of hepatocellular carcinoma: correlation with histological characteristics.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Cell Differentiation; Contrast Media; Edetic Acid; Female; Humans; Image Interpretation, Computer-Assisted; Liver Neoplasms; Male; Middle Aged; Pyridoxal Phosphate | 2008 |
Detection of neuroendocrine liver metastases with MnDPDP-enhanced MRI.
Topics: Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Iohexol; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neuroendocrine Tumors; Pyridoxal Phosphate; Tomography, X-Ray Computed | 2009 |
Tumor models and specific contrast agents for small animal imaging in oncology.
Topics: Animals; Biomarkers, Tumor; Clinical Trials as Topic; Contrast Media; Diagnostic Imaging; Disease Models, Animal; Edetic Acid; Humans; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Models, Animal; Molecular Diagnostic Techniques; Neoplasm Transplantation; Neoplasms, Experimental; Pyridoxal Phosphate; Rhabdomyosarcoma | 2009 |
Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI?
Topics: Aged; Colorectal Neoplasms; Contrast Media; Dextrans; Edetic Acid; Fatty Liver; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Neoplasm Staging; Organometallic Compounds; Pyridoxal Phosphate; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
Liver lesion detection and characterization with sequential use of hepatobiliary contrast agent mangafodipir trisodium and gadolinium-DTPA in a single imaging protocol.
Topics: Adult; Aged; Contrast Media; Edetic Acid; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate; Statistics, Nonparametric | 2002 |
Exploring multifunctional features of necrosis avid contrast agents.
Topics: Animals; Contrast Media; Edetic Acid; Gadolinium DTPA; Half-Life; Liver Diseases; Liver Neoplasms; Mesoporphyrins; Metalloporphyrins; Myocardial Infarction; Necrosis; Organic Chemicals; Pyridoxal Phosphate; Rats; Rhabdomyosarcoma; Swine; Tissue Distribution | 2002 |
Breast carcinoma metastases to the liver simulating cirrhosis.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Contrast Media; Edetic Acid; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Manganese; Middle Aged; Pyridoxal Phosphate | 2002 |
MnDPDP enhanced magnetic resonance imaging of focal liver lesions.
Topics: Adenoma, Liver Cell; Adult; Aged; Cholangiocarcinoma; Contrast Media; Edetic Acid; Female; Focal Nodular Hyperplasia; Hemangioma; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate | 2002 |
[Organ specific MRI contrast media in general practice].
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Humans; Iron; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetite Nanoparticles; Neoplasm Staging; Neoplasms; Organ Specificity; Oxides; Pancreatic Neoplasms; Pyridoxal Phosphate; Sensitivity and Specificity; Tomography, Spiral Computed | 2002 |
Mn-DPDP-enhanced 24-h delayed-scan MRI of hepatocellular carcinoma is correlated with histology.
Topics: Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Manganese; Pyridoxal Phosphate; Time Factors | 2004 |
Improved image contrast with mangafodipir trisodium (MnDPDP) during MR-guided percutaneous cryosurgery of the liver.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Contrast Media; Cryosurgery; Edetic Acid; Female; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate; Retrospective Studies | 2003 |
[Comparative study of four GRE sequences in MnDPDP-enhanced magnetic resonance imaging for primary hepatocellular carcinoma].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Female; Humans; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate | 2003 |
Mangafodipir prevents liver injury induced by acetaminophen in the mouse.
Topics: Acetaminophen; Animals; Antibodies, Monoclonal; Antioxidants; Carcinoma, Hepatocellular; Caspase 3; Caspase Inhibitors; Cell Line, Tumor; Cytochromes c; Edetic Acid; Enzymes; fas Receptor; Female; Glutathione; Humans; Liver; Liver Failure, Acute; Liver Neoplasms; Mice; Mice, Inbred BALB C; Oxidoreductases; Pyridoxal Phosphate; Reactive Oxygen Species; Superoxides; Survival Analysis | 2003 |
Small (
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Edetic Acid; Female; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate; Tomography, X-Ray Computed | 2004 |
MRI for detection of hepatocellular carcinoma: comparison of mangafodipir trisodium and gadopentetate dimeglumine contrast agents.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Predictive Value of Tests; Pyridoxal Phosphate; ROC Curve; Sensitivity and Specificity | 2004 |
Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Topics: Adult; Aged; Contrast Media; Dextrans; Diagnosis, Differential; Edetic Acid; Female; Ferrosoferric Oxide; Humans; Image Enhancement; Infusions, Intravenous; Injections, Intravenous; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Oxides; Pyridoxal Phosphate; ROC Curve | 2004 |
Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Colonic Neoplasms; Contrast Media; Edetic Acid; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Pyridoxal Phosphate; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2005 |
Detection of liver metastases from gastrointestinal cancer: comparision of high resolution MnDPDP enhanced MRI and FDG-PET.
Topics: Adenocarcinoma; Adult; Aged; Contrast Media; Edetic Acid; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Pyridoxal Phosphate; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Hepatocyte-targeted MR contrast agents: contrast enhanced detection of liver cancer in diffusely damaged liver.
Topics: Animals; Carbon Tetrachloride; Contrast Media; Dextrans; Edetic Acid; Female; Ferrosoferric Oxide; Hepatitis, Animal; Hepatocytes; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Oxides; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley | 2005 |
Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Edetic Acid; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Pyridoxal Phosphate; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Mangafodipir trisodium-enhanced magnetic resonance imaging for evaluation of pancreatic mass and mass-like lesions.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Pancreas; Pancreatic Neoplasms; Pancreatitis; Pyridoxal Phosphate | 2006 |
Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Echinococcosis, Hepatic; Edetic Acid; Female; Focal Nodular Hyperplasia; Hemangioma; Humans; Image Enhancement; Infusions, Intravenous; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate | 2006 |
Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination.
Topics: Aged; Colorectal Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Edetic Acid; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Prospective Studies; Pyridoxal Phosphate; ROC Curve; Sensitivity and Specificity | 2008 |
The use of 18F-FDG PET/CT in colorectal liver metastases--comparison with CT and liver MRI.
Topics: Aged; Colorectal Neoplasms; Contrast Media; Edetic Acid; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Pyridoxal Phosphate; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2008 |
Differentiation of hepatomas from nonhepatomatous masses: use of MnDPDP-enhanced MR images.
Topics: Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Edetic Acid; Hemangioma, Cavernous; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Pyridoxal Phosphate; Retrospective Studies | 1994 |
Experimental liver cancers: Mn-DPDP-enhanced rims in MR-microangiographic-histologic correlation study.
Topics: Angiography; Animals; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Liver Neoplasms; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Male; Neoplasm Transplantation; Pyridoxal Phosphate; Rabbits; Rats; Rats, Wistar | 1993 |
Hepatobiliary contrast material: a magic bullet for sensitivity and specificity?
Topics: Contrast Media; Edetic Acid; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Pyridoxal Phosphate; Sensitivity and Specificity; Tomography, X-Ray Computed | 1993 |
Comparison of gadolinium chelates with manganese-DPDP for liver lesion detection and characterization: preliminary results.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Cysts; Edetic Acid; Female; Gadolinium; Gadolinium DTPA; Hemangioma; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Organometallic Compounds; Pentetic Acid; Prospective Studies; Pyridoxal Phosphate; Tomography, X-Ray Computed | 1996 |
Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
Topics: Adenocarcinoma; Adenoma, Islet Cell; Adipose Tissue; Adult; Aged; Aged, 80 and over; Blood-Brain Barrier; Body Water; Brain; Carcinoid Tumor; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Dose-Response Relationship, Drug; Edetic Acid; Female; Humans; Image Enhancement; Infusions, Intravenous; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pancreas; Pancreatic Diseases; Pancreatic Neoplasms; Pyridoxal Phosphate; Safety; Sensitivity and Specificity; Time Factors | 1998 |
Influence of the hepatobiliary contrast agent mangafodipir trisodium (MN-DPDP) on the imaging properties of abdominal organs.
Topics: Abdomen; Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Kidney; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pancreas; Pyridoxal Phosphate; Spleen | 1998 |
Sequential use of gadolinium chelate and mangafodipir trisodium for the assessment of focal liver lesions: initial observations.
Topics: Adult; Aged; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Focal Nodular Hyperplasia; Gadolinium; Hemangioma; Humans; Image Enhancement; Liver Abscess; Liver Diseases; Liver Neoplasms; Lymphoma; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate; Sensitivity and Specificity | 2000 |
Technical report: lymph node enhancement at MRI with MnDPDP in primary hepatic carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Humans; Liver Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Manganese; Pyridoxal Phosphate | 2001 |
The value of MnDPDP enhancement during MR guided laser interstitial thermoablation of liver tumors.
Topics: Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Laser Coagulation; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate | 2001 |
Clinical and cost effectiveness of a new hepatocellular MRI contrast agent, mangafodipir trisodium, in the preoperative assessment of liver resectability.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Contrast Media; Cost-Benefit Analysis; Edetic Acid; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate; Sensitivity and Specificity | 2001 |
Correlation of MRI and CT findings with histopathology in hepatic angiomyolipoma.
Topics: Adult; Aged; Angiomyolipoma; Contrast Media; Edetic Acid; Female; Gadolinium DTPA; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Pyridoxal Phosphate; Retrospective Studies; Tomography, X-Ray Computed | 2001 |
Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases.
Topics: Acetates; Animals; Bile; Contrast Media; Duodenum; Edetic Acid; Female; Gadolinium; Gadolinium DTPA; Gallbladder; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Mice; Models, Statistical; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate; Rats; Time Factors | 1992 |
Contrast-enhanced MR imaging of the liver.
Topics: Contrast Media; Edetic Acid; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Pyridoxal Phosphate | 1992 |
[The clinical value of Mn-DPDP: a new paramagnetic hepatobiliary contrast medium for magnetic resonance tomography of the liver].
Topics: Adult; Aged; Contrast Media; Diagnosis, Differential; Drug Evaluation; Edetic Acid; Female; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Prospective Studies; Pyridoxal Phosphate | 1991 |
Manganese-DPDP as a hepatobiliary contrast agent in the magnetic resonance imaging of liver tumors. Results of clinical phase II trials in Germany including 141 patients.
Topics: Biliary Tract; Contrast Media; Drug Evaluation; Drug Tolerance; Edetic Acid; Germany; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Manganese; Pyridoxal Phosphate | 1991 |
Clinical hepatic imaging with paramagnetic positive enhancers.
Topics: Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Hemangioma; Humans; Liver; Liver Neoplasms; Manganese; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate | 1991 |